Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-331-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-03-08"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20110308.22.2-331-000"2
lpv:hasSubsequent	lp_eu:2011-03-08-Speech-2-331-5002
lpv:speaker	lp:Françoise Grossetête2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3 member; Delegation for relations with the countries of Central America (2009-09-16--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Union pour un Mouvement Populaire (2009-07-14--2014-06-30)3
lpv:translated text	"It was absolutely crucial for the report to take age-based health inequalities into account, as it has now done. Age-based health inequalities result in limited access to adequate healthcare and innovative treatments. Older people should be able to make use of medications which have been tested for effectiveness and safety on people of the same age. People of this age group are still excluded too often from clinical trials. The average age of patients participating in clinical trials of treatments for high blood pressure is 63, yet 44% of patients are older than 70 when first diagnosed with this problem. Without further ado, the Union and the Member States must plan for the social and economic consequences of an ageing European population and take this demographic change into account."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph